Detalhe da pesquisa
1.
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer.
Int J Mol Sci
; 25(2)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38256268
2.
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells.
Int J Mol Sci
; 24(6)2023 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982282
3.
Obesity and Risk for Lymphoma: Possible Role of Leptin.
Int J Mol Sci
; 23(24)2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555171
4.
Innovative therapies in Ewing Sarcoma.
Adv Anat Pathol
; 21(1): 44-62, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24316910
5.
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Front Immunol
; 15: 1293931, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469299
6.
Knowing the myeloid-derived suppressor cells: Another enemy of sarcomas patients.
Int Rev Cell Mol Biol
; 375: 93-116, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967155
7.
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.
Cancers (Basel)
; 14(6)2022 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326620
8.
Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1.
Oncogene
; 41(18): 2638-2650, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354905
9.
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Clin Cancer Res
; 28(17): 3658-3668, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727601
10.
The bitter side of epigenetics: variability and resistance to chemotherapy.
Epigenomics
; 13(5): 397-403, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29932342
11.
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.
Oncogene
; 40(39): 5843-5853, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34345016
12.
The clinical relevance of molecular genetics in soft tissue sarcomas.
Adv Anat Pathol
; 17(3): 162-81, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20418671
13.
Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials.
Front Genet
; 11: 578011, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33024443
14.
An inducible ectopic expression system of EWSR1-FLI1 as a tool for understanding Ewing sarcoma oncogenesis.
PLoS One
; 15(6): e0234243, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502203
15.
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis.
Sci Adv
; 6(43)2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097530
16.
Treatment-driven selection of chemoresistant Ewing sarcoma tumors with limited drug distribution.
J Control Release
; 324: 440-449, 2020 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32497782
17.
Correction: Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Oncotarget
; 8(38): 64652, 2017 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28969102
18.
HMGA2 overexpression predicts relapse susceptibility of blastemal Wilms tumor patients.
Oncotarget
; 8(70): 115290-115303, 2017 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29383160
19.
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Oncotarget
; 8(7): 11173-11186, 2017 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28061436
20.
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein.
Oncotarget
; 7(29): 46283-46300, 2016 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27317769